Federal Register Notices
View Federal Register notices of proposed exclusive licenses. Clicking on the "View" links will display the Federal Register Notice in a new tab. You can also search directly on the Federal Register site.
| View | Date Published | Title | Comments Close On | Dates |
|---|---|---|---|---|
| View | Prospective Grant of Exclusive License: Anthrax Lethal Factor Is a MAPK Kinase Protease | Only license applications which are received by the National Institutes of Health on or before March 13, 2006 will be considered. | ||
| View | Prospective Grant of Exclusive License: Treatment of Cardiovascular Conditions With Nitrite Therapy | Only written comments and/or application for a license, which are received by the NIH Office of Technology Transfer on or before February 28, 2006 will be considered. | ||
| View | Prospective Grant of Exclusive License: Software for Predicting Molecular Properties and Pathogen Detection | Only written comments and/or applications for a license received by the NIH Office of Technology Transfer on or before February 28, 2006 will be considered. | ||
| View | Prospective Grant of Exclusive License: Fusion Proteins Comprising Circularly Permuted Ligands | Only written comments and/or applications for a license which are received by the NIH Office of Technology Transfer on or before February 28, 2006 will be considered. | ||
| View | Prospective Grant of Exclusive License: Implants for Sustained Ocular Therapeutic Agent Delivery | Only written comments and/or applications for a license received by the NIH Office of Technology Transfer on or before February 28, 2006 will be considered. | ||
| View | Prospective Grant of Exclusive License: Cleaning Mucus From Endotracheal Tubes | Only written comments and/or applications for a license received by the NIH Office of Technology Transfer on or before January 9, 2006 will be considered. | ||
| View | Government-Owned Inventions; Availability for Licensing | |||
| View | Prospective Grant of Exclusive License: North-2'-Deoxy-Methanocarbathmydines as Antiviral Agents Against Poxvirus | Only written comments and/or application for a license which are received by the NIH Office of Technology Transfer on or before December 6, 2005 will be considered. | ||
| View | Government-Owned Inventions; Availability for Licensing | |||
| View | Prospective Grant of Exclusive License: Development and Use of Cripto-1 as a Biomarker and Treatment for Neurodegenerative Disease | Only written comments and/or applications for a license, which are received by the NIH Office of Technology Transfer on or before October 4, 2005 will be considered. | ||
| View | Prospective Grant of Exclusive License: Adaphostin as a Novel Cancer Therapy | Only written comments and/or applications for a license which are received by the NIH Office of Technology Transfer on or before October 3, 2005 will be considered. | ||
| View | Government-Owned Inventions; Availability for Licensing | |||
| View | Prospective Grant of an Exclusive License: Therapeutics for the Treatment of Kidney Cancer and Thyroid Neoplasms | Only written comments and/or license applications which are received by the National Institutes of Health on or before October 3, 2005 will be considered. | ||
| View | Prospective Grant of an Exclusive License: Anti-Cancer Vaccines | Only written comments and/or license applications which are received by the National Institutes of Health on or before October 3, 2005 will be considered. | ||
| View | Prospective Grant of Exclusive License: Treatment of Inflammatory Diseases Using Ghrelin | Only written comments and/or application for a license, which are received by the NIH Office of Technology Transfer on or before October 3, 2005 will be considered. | ||
| View | Prospective Grant of Exclusive License: Use of HIV-Dependent Expression Constructs and Uses Therefor for the Development of FDA-Approvable HIV Diagnostic Kits | Only written comments and/or application for a license, which are received by the NIH Office of Technology Transfer on or before September 20, 2005 will be considered. | ||
| View | Government-Owned Inventions; Availability for Licensing | |||
| View | Government-Owned Inventions; Availability for Licensing and Cooperative Research and Development Agreement (CRADA): Aminoflavone Prodrug | |||
| View | Prospective Grant of Exclusive License: Mesothelin, a Differentiation Antigen Present on Mesothelium, Mesotheliomas and Ovarian Cancers and Methods and Kits for Targeting | Only written comments and/or applications for a license which are received by the NIH Office of Technology Transfer on or before September 12, 2005 will be considered. | ||
| View | Prospective Grant of Exclusive License: Method for Diagnosis of Atherosclerosis | Only written comments and/or application for a license, which are received by the NIH Office of Technology Transfer on or before September 6, 2005 will be considered. | ||
| View | Prospective Grant of Exclusive License: Heat Induced Gene Expression to Treat Cancer | Only written comments and/or license applications that are received by the National Institutes of Health on or before September 6, 2005 will be considered. | ||
| View | Government-Owned Inventions; Availability for Licensing | |||
| View | Prospective Grant of Exclusive License: Diagnostics of Fungal Infections | N/A. | ||
| View | Government-Owned Inventions; Availability for Licensing | |||
| View | Opportunity for a Cooperative Research and Development Agreement (CRADA) for Research and Development of Vigabatrin as a Potential Pharmacotherapy for the Treatment of Cocaine and Methamphetamine Dependence | NIDA will consider all proposals received within 45 days of the date of publication of this notice. This notice is active until July 5, 2005. |